InvestorsHub Logo
Followers 16
Posts 929
Boards Moderated 0
Alias Born 04/09/2015

Re: polarbear77 post# 121641

Monday, 09/25/2017 10:52:46 PM

Monday, September 25, 2017 10:52:46 PM

Post# of 463625
Great questions Polar - putting a lot of our thoughts into words.

"Therefore isn't the most logical reason for the delay the FDA guidelines and trial protocols announcements/negotiations?

What else could it be?"


Tomorrow is a mystery - presentation at 330 - seems like no webcast for Anavex - we don't even know if Missling will be there for sure.

What would be worthy of all this silence? If it was an announcement about a Biogen licensing deal for MS would that make us back out of the big July Alzheimers conference? I don't think it would.

It really is just about a year (last Sept 28th or so) since the Biogen interest was announced - just saying---

https://insiderfinancial.com/anavex-life-sciences-corp-nasdaqavxl-and-biogen-inc-nasdaqbiib-a-perfect-match/

I'm trying not to get my hopes up but this has all been very strange.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News